Clinical Trial Update: Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents [Phase 2]

View source ↗

Summary

Phase 2 study assessing long-term immunological persistence and response to a booster after GSK meningococcal ABCWY vaccination in adolescents; completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Meningococcal
• Meningococcal Infection

Drugs mentioned

• ABCWY meningococcal vaccine (Meningococcal vaccine ABCWY)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 2 | Status: COMPLETED | Results posted: 2019-08-20